HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,612,726 | +65.9% | 173,108 | +56.7% | 0.04% | +75.0% |
| Q2 2023 | $3,985,014 | -21.7% | 110,480 | -17.1% | 0.02% | -28.6% |
| Q1 2023 | $5,087,214 | -15.3% | 133,208 | +26.2% | 0.03% | -20.0% |
| Q4 2022 | $6,005,169 | +263.7% | 105,539 | +181.3% | 0.04% | +250.0% |
| Q2 2022 | $1,651,000 | +624.1% | 37,513 | +603.5% | 0.01% | +900.0% |
| Q4 2020 | $228,000 | +53.0% | 5,332 | -54.1% | 0.00% | 0.0% |
| Q2 2017 | $149,000 | -47.2% | 11,625 | -42.2% | 0.00% | -50.0% |
| Q1 2014 | $282,000 | – | 20,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |